Trials / Unknown
UnknownNCT06017739
Expiratory Flow Accelerator (Efa) vs Efa + High Flow in Chronic COPD and Bronchiectasis
Hypersecreting Patients (COPD And/or Bronchiectasic) Comparing 2 Technologies: Efa vs Efa + High Flow
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Azienda Socio Sanitaria Territoriale della Valle Olona · Academic / Other
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to compare the efficacy of using EFA technology versus the combination of EFA + high flow in hypersecretory patients COPD and bronchiectasis
Detailed description
After being informed about the study and potential risks, all patients giving written informed consent will undergo a 13-weeks trial period: 6 weeks of one technology (EFA / EFA+ HIGH FLOW), 1- wash out week and 6- weeks of the other technology in a cross over randomized trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bronchial Clearance A | EFA technology: the patient has to breathe at tidal volume by a mouthpiece at level 5 for half an hour twice a day. |
| DEVICE | Bronchial Clearance B | High Flow Technology: patient has to wear nasal cannula and breathe his nose for one hour twice a day. After he has to use EFA technology level 5 for half an hour twice a day. |
Timeline
- Start date
- 2023-10-09
- Primary completion
- 2024-07-18
- Completion
- 2025-01-18
- First posted
- 2023-08-30
- Last updated
- 2024-02-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06017739. Inclusion in this directory is not an endorsement.